Page 132 - 2019年1月第30卷第2期
P. 132

[ 8 ]  ABBAS H,BENSADOUN RJ. Trolamine emulsion for     1447-1453.
             the prevention of radiation dermatitis in patients with  [19]  THÉBERGE V,HAREL F,DAGNAULT A. Use of axil-
             squamous cell carcinoma of the head and neck[J]. Support  lary deodorant and effect on acute skin toxicity during ra-
             Care Cancer,2012,20(1):185-190.                    diotherapy for breast cancer:a prospective randomized
        [ 9 ]  陈琴,谢淑萍.三乙醇胺乳膏对直肠癌放射性皮肤损伤预                        noninferiority trial[J]. Int J Radiat Oncol Biol Phys,2009,
             防及治疗效果观察[J].中国现代医生,2011,49(32):                    75(4):1048-1052.
             120-121.                                      [20]  AHMADLOO N,KADKHODAEI B,OMIDVARI SH,
        [10]  俞斐,童金龙,鲁世慧.三乙醇胺乳膏防治头颈部肿瘤放                         et al. Lack of prophylactic effects of aloe vera gel on radia-
             射性皮炎的临床观察[J].中国药房,2015,26(14):1962-                tion induced dermatitis in breast cancer patients[J]. Asian
             1964.                                              Pac J Cancer Prev,2017,18(4):1139-1143.
        [11]  张建清,张仑,张莉.三乙醇胺(比亚芬)防治头颈部肿瘤                   [21]  GEARA FB,EID T,ZOUAIN N,et al. Randomized,pro-
             放射性皮肤损伤的疗效观察[J].实用肿瘤杂志,2011,26                     spective,open-label phase Ⅲ trial comparing mebo oint-
            (3):269-271.                                        ment with biafine cream for the management of acute der-
        [12]  张明,陈琳,吴琦.三乙醇胺乳膏预防乳腺癌放疗皮肤损                         matitis during radiotherapy for breast cancer[J]. Am J Clin
             伤的临床研究[J].实用医院临床杂志,2010,7(1):65-66.                Oncol,2018. DOI:10.1097/COC.0000000000000460.
        [13]  TROTTI A,BYHARDT R,STETZ J,et al. Common Tox-  [22]  KIROVA YM,FROMANTIN I,DE RYCKE Y,et al. Can
             icity Criteria:version 2.0. an improved reference for grad-  we decrease the skin reaction in breast cancer patients us-
             ing the acute effects of cancer treatment:impact on radio-  ing hyaluronic acid during radiation therapy? Results of
             therapy[J]. Int J Radiat Oncol Biol Phys,2000,47(1):  phase Ⅲ randomised trial[J]. Radiother Oncol,2011,100
             13-47.                                             (2):205-209.
        [14]  COX JD,STETZ J,PAJAK TF. Toxicity criteria of the Ra-  [23]  LIGUORI V,GUILLEMIN C,PESCE GF,et al. Dou-
             diation therapy oncology group(RTOG)and the Europe-  ble-blind,randomized clinical study comparing hyaluron-
             an organization for research and treatment of cancer  ic acid cream to placebo in patients treated with radiother-
            (EORTC)[J]. Int J Radiat Oncol Biol Phys,1995,31(5):  apy[J]. Radiother Oncol,1997,42(2):155-161.
             1341-1346.                                    [24]  PRIMAVERA G,CARRERA M,BERARDESCA E,et al.
        [15]  AGUAYO-ALBASINI JL,FLORES-PASTOR B,SO-            A double-blind,vehicle-controlled clinical study to evalu-
             RIA-ALEDO V. GRADE system:classification of quality  ate the efficacy of MAS065D(XClair ),a hyaluronic ac-
                                                                                            TM
             of evidence and strength of recommendation[J]. Cir Esp,  id-based formulation,in the management of radiation-in-
             2014,92(2):82-88.                                  duced dermatitis[J]. Cutan Ocul Toxicol,2006,25(3):
        [16]  WONG RK,BENSADOUN RJ,BOERS-DOETS CB,              165-171.
             et al. Clinical practice guidelines for the prevention and  [25]  LEONARDI MC,GARIBOLDI S,IVALDI GB,et al. A
             treatment of acute and late radiation reactions from the  double-blind,randomised,vehicle-controlled clinical study
             MASCC skin toxicity study group[J]. Support Care Can-  to evaluate the efficacy of MAS065D in limiting the ef-
             cer,2013,21(10):2933-2948.                         fects of radiation on the skin:interim analysis[J]. Eur J
        [17]  MILLER RC,SCHWARTZ DJ,SLOAN JA,et al. Mo-         Dermatol,2008,18(3):317-321.
             metasone furoate effect on acute skin toxicity in breast  [26]  HEMATI S,ASNAASHARI O,SARVIZADEH M,et al.
             cancer patients receiving radiotherapy:a phase Ⅲ dou-  Topical silver sulfadiazine for the prevention of acute der-
             ble-blind,randomized trial from the north central cancer  matitis during irradiation for breast cancer[J]. Support Care
             treatment group N06C4[J]. Int J Radiat Oncol Biol Phys,  Cancer,2012,20(8):1613-1618.
             2011,79(5):1460-1466.                         [27]  KOLE AJ,KOLE L,MORAN MS. Acute radiation derma-
        [18]  POMMIER P,GOMEZ F,SUNYACH MP,et al. Phase Ⅲ       titis in breast cancer patients:challenges and solutions[J].
             randomized trial of Calendula officinalis compared with  Breast Cancer,2017. DOI:10.2147/BCTT.S109763.
             trolamine for the prevention of acute dermatitis during ir-  (收稿日期:2018-08-03  修回日期:2018-11-12)
             radiation for breast cancer[J]. J Clin Oncol,2004,22(8):                           (编辑:陈 宏)







        中国药房    2019年第30卷第2期                                               China Pharmacy 2019 Vol. 30 No. 2  ·263  ·
   127   128   129   130   131   132   133   134   135   136   137